Résumé

Why Patients should join WOOs – what do patients think of WOOs and research in general?

The WOO study design has increasingly become part of drug development. WOO trials exploit the ‘window’ of time after cancer diagnosis, typically prior to initiation of cancer therapy (usually surgery with curative intent). In presurgical WOO trials, patients with treatment naïve or early- stage disease are treated for a brief “window” period with a novel therapy followed by surgical resection. Unlike neoadjuvant trials, “window” period is kept short (a few weeks) to ensure the that surgery is not delayed.

User

Dr. Angel Arnaout MD MSC FRCSC MBA

Ottawa, Ontario, Canada

Co-Lead, Window of Opportunity Clinical Trials Program, Ontario Institute of Cancer Research, Professor of Surgery, University of Ottawa

User

Carol Gordon CPA, CFA

Ottawa, Ontario, Canada

Member, Patient & Family Advisory Council, Ontario Institute for Cancer Research

Commentaires (0)